Healthpeak Properties, Inc. (NYSE:HCP) has recently disclosed details concerning a significant financial undertaking. On February 5, 2025, Healthpeak OP, LLC, Healthpeak Properties, Inc., DOC DR Holdco, LLC, and DOC DR, LLC finalized an underwriting agreement with underwriters for the sale of $500.0 million aggregate principal amount of 5.375% senior unsecured notes due 2035, as per a Form 8-K filing submitted to the U.S. Securities and Exchange Commission.
The underwriting agreement contains customary representations, warranties, covenants, and conditions, with Healthpeak OP, Healthpeak Properties, DOC Holdco, and DOC LLC agreeing to indemnify the Underwriters against certain liabilities that may arise from the Offering. The anticipated net proceeds from this offering are estimated to be approximately $493.2 million, following the deduction of underwriting discount and related expenses.
The closing of this offering is expected to occur on February 14, 2025, subject to customary closing conditions.
The summary of the Underwriting Agreement terms in the recent filing is available for public review. It is essential to note that neither the press release nor the Form 8-K filing constitutes an offer to sell, solicitation to buy securities, or a guarantee of sale in any jurisdiction where it may be deemed unlawful.
Furthermore, the press release announcing the pricing of this Offering is available for reference alongside the original filing made to the SEC.
The offering is orchestrated through a joint effort of financial institutions acting as joint book-running managers, including Wells Fargo Securities, BNP PARIBAS, Goldman Sachs & Co. LLC, PNC Capital Markets LLC, and TD Securities. These entities are facilitating the offering in compliance with an effective shelf registration statement and related prospectus on file with the SEC.
Healthpeak Properties, Inc., a reputable REIT and S&P 500 company focused on healthcare-related real estate, is driving this initiative. Potential investors seeking further information on the offering can refer to the available prospectus and related material.
This news release may contain forward-looking statements subject to inherent risks and uncertainties. Healthpeak urges caution in reliance on such statements, noting that actual results may deviate materially from projections due to various factors.
For further details, investors can reach out to Andrew Johns, CFA, Senior Vice President – Investor Relations at 720-428-5400.
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read HashiCorp’s 8K filing here.
About HashiCorp
HashiCorp, Inc engages in the provision of multi-cloud infrastructure automation solutions worldwide. The company offers infrastructure provisioning products, including Terraform, that enables IT operations teams to apply an Infrastructure-as-Code approach, where processes and configuration required to support applications are codified and automated instead of being manual and ticket-based; Packer, that provides a consistent way to define the process of transforming the raw source inputs into a production worthy artifact, across any environment or packaging format; and Vagrant, that allows teams to define how development environments are set up.
Read More
- Five stocks we like better than HashiCorp
- Quiet Period Expirations Explained
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market